Huntsman Cancer Institute

Cancer has a way of changing everything, but even in the toughest moments, hope shines through. After losing her husband and later facing ovarian cancer herself, Karon Cook found strength in small victories and meaningful celebrations. To honor these milestones, she made a special donation to us: https://bit.ly/4bZfXQB

New research, led by Thomas Varghese Jr. MD, MS, MBA, FACS, MAMSE and Neli Ulrich, PhD, MS, shows the power of personalized exercise programs for lung cancer surgery patients — especially women. The Precision Exercise Prescription (PEP) trial demonstrates that tailored, remotely monitored exercise plans can improve physical function and reduce fatigue, bridging gaps in care for rural and underserved patients. This study paves the way for making personalized exercise a standard part of cancer care. https://bit.ly/3FsUljD

When Doug Woods swabbed his cheek at a University of South Carolina event, he never expected it would lead to saving someone’s life a few short weeks later. Gina Poirier, across the country in Utah, was in urgent need of a stem cell transplant. Doug was her perfect match. Years after Gina’s successful transplant, they finally met in person. Read their story and learn how a simple cheek swab can save a life: https://bit.ly/3DClMXs

Colorectal cancer is the third most common diagnosed cancer in the United States. Early detection can be life-saving, which is why we urge everyone to prioritize regular screenings starting at age 45. There's no one-size-fits-all approach when it comes to screening for colorectal cancer. Your screening choice depends on various factors, including personal and family medical history. Learn about your options to find what works best for you: https://bit.ly/48UFiYK

A groundbreaking genomic study conducted in collaboration between Huntsman Cancer Institute and Emory University reveals that ovarian cancer mutations are nearly identical across populations—with some key differences that may be clinically significant. Led by Katherine Lawson-Michod, MPH, PhD, and Jennifer Doherty, MS, PhD, this research highlights the importance of diversity in cancer genomics and could help refine treatment strategies for all patients. Read more: https://bit.ly/4bHpifC

“It makes you go from being a patient to being a human." After Ruth Hill was diagnosed with multiple myeloma, an incurable blood cancer, she felt hopeless and scared. A referral to our palliative care team changed that. With their support, she found a renewed sense of control over her life. Read Ruth's story and learn about our palliative care team: https://bit.ly/3YT58Lo

Our staff is kicking off Colorectal Cancer Awareness Month with Dress in Blue Day! Colorectal cancer is the third most common cancer diagnosis and the third leading cause of cancer death. Screening can help find it early, when treatment is most effective. Talk to your doctor about the right time for you to get screened.

"I am grateful to now be able to be a voice, to share hope with my community, and to encourage women to pay attention to their bodies, and to be their own advocate." After Sara was diagnosed with ovarian cancer, she felt overwhelmed and uncertain about the future. Then, a friend introduced her to our Breast & Gynecologic Cancers Research Advocate (BGCRA) Committee—a group of patients, survivors, and researchers working together to ensure the patient voice is at the heart of cancer research. Each year, the BGCRA Committee hosts the Project Next Symposium, where they present their research and share insights. This year’s event is on March 21, from 12:00–6:00 PM, and is open to patients, caregivers, and researchers who want to be part of the conversation. Don’t miss out! Get all the details: https://bit.ly/4bwgnOa

Mammograms are the best way to catch breast cancer early, when it is easier to treat. But some people may wonder if a mammogram will work for their breast type. Breast radiologist Dr. Nicole Winkler breaks down what you need to know in our latest blog. https://bit.ly/4iqSlGt

Congratulations to Don Ayer, PhD, Kate Warde PhD, and Robert Judson-Torres, PhD for securing over $2 million in grants from the American Cancer Society! These grants will drive groundbreaking cancer research and support early-career scientists. We are deeply grateful to American Cancer Society for their commitment to advancing science and improving patient outcomes. https://bit.ly/3F87eiQ